
X
Lilly raises 2020 earnings forecast on pandemic stockpiling
https://pharmaphorum.com/news/lilly-raises-2020-earnings-forecast-on-pandemic-stockpiling/
New phase 3b trial results show Lilly’s Trulicity combined with an SGLT2 inhibitor failed to show any benefits above and beyond Trulicity’s blood glucose lowering.